This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Questions about our CME?
Questions about our CME?
Hang on a second…

This CME Activity has expired and is no longer available for credit.

Navigating Updated Guidelines and New Therapies for the Diagnosis and Treatment of Heart Failure

Navigating Updated Guidelines and New Therapies for the Diagnosis and Treatment of Heart Failure



Time to Complete

1 hour


December 18, 2017


December 18, 2018
Add to Queue

Maximum Credits

1.00 / AMA PRA Category 1 CreditTM
1.00 / CNE for Nurses (0.40 pharmacotherapy hours)
1.00 / CE for Pharmacists (0.10 CEUs)
1.00 / CPEU for Registered Dietitians

Accredited Provider

This activity is jointly provided by Global Education Group and the Cardiometabolic Health Congress.

Commercial Supporter

This activity is supported in part by an educational grant from Novartis Pharmaceuticals Corporation.

Program Description

As the prevalence of cardiometabolic risk factors, such as obesity, high blood pressure, diabetes, abnormal cholesterol levels, and hypercoagulability, continue to increase, as well as aging of the population, the incidence of heart failure (HF) will continue to rise, along with the unmet needs of patients. Recent studies have shown that only 40% of patients with HF receive evidence-based treatment recommended by guidelines; less than half of patients with HF take beta-blockers; and only a third take angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin-receptor blockers (ARBs). Additionally, only 7% of African Americans diagnosed with HF are receiving guideline recommended fixed-dose hydralazine and isosorbide dinitrate.

This symposium will focus on identifying the risk of HF in patients with cardiometabolic disease, provide an overview on the most recent focused update of the HF guidelines, identify the safety and efficacy of recently approved pharmacotherapies for HF, and implement coordination of care strategies to optimize patient outcomes. Expert faculty will also provide patient cases to provide participants with real world solutions to clinical challenges.

Intended Audience

The educational design of this activity addresses the needs of US-based healthcare professionals, including: physicians (MDs), nurse practitioners (NPs), physician assistants (PAs), nurses, pharmacists (ACPE), dieticians (CDR), and other allied health professionals.

Educational Objectives

Upon completion of this activity, participants should be able to:

  • List the most recent guidelines for the diagnosis and treatment of patients with HF
  • Describe appropriate treatment regimens for high risk HF patients, considering the safety, efficacy, and pharmacology of newer HF pharmacotherapy
  • Explain care coordination strategies and protocols within a multidisciplinary team, and patient education to optimize HF patient outcomes during hospitalization and post discharge to reduce readmission rates

Conflict Of Interest Disclosure Policy

Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.


Keith C. Ferdinand, MD, FACC, FAHA

Professor of Medicine
Tulane University School of Medicine
Tulane Heart and Vascular Institute
New Orleans, LA

Dr. Ferdinand discloses the following:
Consultant/Independent Contractor: Quantum Genomics, Novartis, Amgen, Sanofi, Eli Lilly
Grant/Research Support: Boehringer Ingelheim

Clyde W. Yancy, MD, MSc, MACP
Magerstadt Professor of Medicine
Professor of Medical Social Sciences
Chief, Div. of Cardiology, Northwestern Univ.
Feinberg School of Medicine
Assoc. Director, Bluhm Cardiovascular Institute
Northwestern Memorial Hospital
Chicago, IL

Dr. Yancy has nothing to disclose.

JoAnn Lindenfeld, MD
Director, Heart Failure and Transplant
Professor of Medicine
Vanderbilt University School of Medicine
Nashville, TN

Dr. Lindenfeld discloses the following:
Consultant/Independent Contractor: Relypsa, VWare, Abbott, Novartis, Edwards, Cariomic
Grant/Research Support: Novartis, AstraZeneca

Accredited Provider Disclosure

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Ashley Marostica, RN, MSN, has nothing to disclose.
Andrea Funk has nothing to disclose.
Liddy Knight has nothing to disclose.
Erin Franceschini, MS, has nothing to disclose.
Karin McAdams has nothing to disclose.




AMA PRA Category 1 Credit(s)TM

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and CMHC. Global is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

Global Education Group designates this virtual activity for a maximum of 1.00 AMA PRA Category 1 CreditTM  . Physicians should claim only the credit commensurate with the extent of their participation in the activity.




CNE Contact Hour(s)

Accreditation Statement

Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Designation Statement

This educational activity for 1.00 contact hour is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

This activity includes 0.40 pharmacotherapy hour.




CE for Pharmacists

Accreditation Statement

Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Designation Statement

Global Education Group designates this continuing education activity for 1.00 contact hour(s) (0.10 CEUs) of the Accreditation Council for Pharmacy Education. This is a knowledge based activity.

Universal Activity Number (UAN): 0530-9999-17-443-H01-P




CPEU Credit

Accreditation Statement

Global Education Group is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR).

Designation Statement

CDR Credentialed Practitioners will receive 1.00 Continuing Professional Education units (CPEUs) for completion of this activities / materials.

CPE Provider #GE012

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and CMHC do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.


To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

For information about the accreditation of this activity, please contact Global Education Group at 303-395-1782 or

If you have any other questions relating to your certificate or other issues with the activity, please contact

Privacy Policy


Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue